163 related articles for article (PubMed ID: 31530630)
1. Therapeutic Targeting of TGFβ Ligands in Glioblastoma Using Novel Antisense Oligonucleotides Reduces the Growth of Experimental Gliomas.
Papachristodoulou A; Silginer M; Weller M; Schneider H; Hasenbach K; Janicot M; Roth P
Clin Cancer Res; 2019 Dec; 25(23):7189-7201. PubMed ID: 31530630
[TBL] [Abstract][Full Text] [Related]
2. Biological Role and Therapeutic Targeting of TGF-β
Seystahl K; Papachristodoulou A; Burghardt I; Schneider H; Hasenbach K; Janicot M; Roth P; Weller M
Mol Cancer Ther; 2017 Jun; 16(6):1177-1186. PubMed ID: 28377490
[TBL] [Abstract][Full Text] [Related]
3. An antisense oligonucleotide targeting TGF-β2 inhibits lung metastasis and induces CD86 expression in tumor-associated macrophages.
Huber-Ruano I; Raventós C; Cuartas I; Sánchez-Jaro C; Arias A; Parra JL; Wosikowski K; Janicot M; Seoane J
Ann Oncol; 2017 Sep; 28(9):2278-2285. PubMed ID: 28911087
[TBL] [Abstract][Full Text] [Related]
4. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
[TBL] [Abstract][Full Text] [Related]
5. TGFβ signaling-induced miRNA participates in autophagic regulation by targeting PRAS40 in mesenchymal subtype of glioblastoma.
Xie Y; Chen L; Zhou J; Yang C; Xu C; Fan X; Tan Y; Wang Y; Kang C; Fang C
Cancer Biol Med; 2020 Aug; 17(3):664-675. PubMed ID: 32944398
[No Abstract] [Full Text] [Related]
6. Active CREB1 promotes a malignant TGFβ2 autocrine loop in glioblastoma.
Rodón L; Gonzàlez-Juncà A; Inda Mdel M; Sala-Hojman A; Martínez-Sáez E; Seoane J
Cancer Discov; 2014 Oct; 4(10):1230-41. PubMed ID: 25084773
[TBL] [Abstract][Full Text] [Related]
7. TGFβ1-induced beta-site APP-cleaving enzyme 2 upregulation promotes tumorigenesis through the NF-κB signalling pathway in human gliomas.
Wang H; Chen Z; Wang S; Gao X; Qian M; Qiu W; Zhang Z; Zhang S; Qi Y; Sun X; Xue H; Guo X; Zhao R; Li G
Mol Oncol; 2020 Feb; 14(2):407-425. PubMed ID: 31856384
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-564 is downregulated in glioblastoma and inhibited proliferation and invasion of glioblastoma cells by targeting TGF-β1.
Jiang C; Shen F; Du J; Hu Z; Li X; Su J; Wang X; Huang X
Oncotarget; 2016 Aug; 7(35):56200-56208. PubMed ID: 27621042
[TBL] [Abstract][Full Text] [Related]
9. RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo.
Friese MA; Wischhusen J; Wick W; Weiler M; Eisele G; Steinle A; Weller M
Cancer Res; 2004 Oct; 64(20):7596-603. PubMed ID: 15492287
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic targeting of oncogenic transforming growth factor-β1 signaling by antisense oligonucleotides in oral squamous cell carcinoma.
Kim SG; Song JY
Oncol Rep; 2012 Aug; 28(2):539-44. PubMed ID: 22581233
[TBL] [Abstract][Full Text] [Related]
11. Isoform-specific effects of transforming growth factor β on endothelial-to-mesenchymal transition.
Sabbineni H; Verma A; Somanath PR
J Cell Physiol; 2018 Nov; 233(11):8418-8428. PubMed ID: 29856065
[TBL] [Abstract][Full Text] [Related]
12. On the in vitro and in vivo properties of four locked nucleic acid nucleotides incorporated into an anti-H-Ras antisense oligonucleotide.
Fluiter K; Frieden M; Vreijling J; Rosenbohm C; De Wissel MB; Christensen SM; Koch T; Ørum H; Baas F
Chembiochem; 2005 Jun; 6(6):1104-9. PubMed ID: 15861430
[TBL] [Abstract][Full Text] [Related]
13. Antiproliferative effect of c-myc antisense phosphorothioate oligodeoxynucleotides in malignant glioma cells.
Broaddus WC; Chen ZJ; Prabhu SS; Loudon WG; Gillies GT; Phillips LL; Fillmore H
Neurosurgery; 1997 Oct; 41(4):908-15. PubMed ID: 9316053
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas.
Corsten MF; Miranda R; Kasmieh R; Krichevsky AM; Weissleder R; Shah K
Cancer Res; 2007 Oct; 67(19):8994-9000. PubMed ID: 17908999
[TBL] [Abstract][Full Text] [Related]
15. Endogenous expression of transforming growth factor beta1 inhibits growth and tumorigenicity and enhances Fas-mediated apoptosis in a murine high-grade glioma model.
Ashley DM; Kong FM; Bigner DD; Hale LP
Cancer Res; 1998 Jan; 58(2):302-9. PubMed ID: 9443409
[TBL] [Abstract][Full Text] [Related]
16. Combined transcriptional and translational targeting of EWS/FLI-1 in Ewing's sarcoma.
Mateo-Lozano S; Gokhale PC; Soldatenkov VA; Dritschilo A; Tirado OM; Notario V
Clin Cancer Res; 2006 Nov; 12(22):6781-90. PubMed ID: 17121899
[TBL] [Abstract][Full Text] [Related]
17. Antitumor mechanisms of systemically administered epidermal growth factor receptor antisense oligonucleotides in combination with docetaxel in squamous cell carcinoma of the head and neck.
Thomas SM; Ogagan MJ; Freilino ML; Strychor S; Walsh DR; Gooding WE; Grandis JR; Zamboni WC
Mol Pharmacol; 2008 Mar; 73(3):627-38. PubMed ID: 18025070
[TBL] [Abstract][Full Text] [Related]
18. Antisense anti-MDM2 oligonucleotides as a novel approach to the treatment of glioblastoma multiforme.
Prasad G; Wang H; Agrawal S; Zhang R
Anticancer Res; 2002; 22(1A):107-16. PubMed ID: 12017271
[TBL] [Abstract][Full Text] [Related]
19. miR-423-5p contributes to a malignant phenotype and temozolomide chemoresistance in glioblastomas.
Li S; Zeng A; Hu Q; Yan W; Liu Y; You Y
Neuro Oncol; 2017 Jan; 19(1):55-65. PubMed ID: 27471108
[TBL] [Abstract][Full Text] [Related]
20. Ezrin-dependent promotion of glioma cell clonogenicity, motility, and invasion mediated by BCL-2 and transforming growth factor-beta2.
Wick W; Grimmel C; Wild-Bode C; Platten M; Arpin M; Weller M
J Neurosci; 2001 May; 21(10):3360-8. PubMed ID: 11331365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
